RxSight (NASDAQ:RXST) Reaches New 52-Week Low Following Analyst Downgrade
Shares of RxSight, Inc. (NASDAQ:RXST – Get Free Report) hit a new 52-week low on Thursday after Wells Fargo & Company lowered their price target on the stock from $35.00 to $22.00. Wells Fargo & Company currently has an equal weight rating on the stock. RxSight traded as low as $14.37 and last traded at […]
